image
Virax Biolabs Group Limited VRAX
Healthcare - Biotechnology - NASDAQ - GB
Watchlist
$ 1.0
-5.45 %
$ 4.34 M
Market Cap
-0.4
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
--74.43%
EBIT Estimate
99.63%
Net Income Estimate
69.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Virax Biolabs Group Limited
image
VRAX has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart VRAX

image
$1.4m$1.4m$1.2m$1.2m$1.0m$1.0m$800.0k$800.0k$600.0k$600.0k$400.0k$400.0k$200.0k$200.0k$0.0$0.020232023202420242025202520262026
EBIT FORECAST

EBIT Forecast Chart VRAX

image
$0.0$0.0($1.0m)($1.0m)($2.0m)($2.0m)($3.0m)($3.0m)($4.0m)($4.0m)($5.0m)($5.0m)($6.0m)($6.0m)($7.0m)($7.0m)20232023202420242025202520262026
NET INCOME FORECAST

Net Income Chart VRAX

image
$0.0$0.0($1.0m)($1.0m)($2.0m)($2.0m)($3.0m)($3.0m)($4.0m)($4.0m)($5.0m)($5.0m)($6.0m)($6.0m)($7.0m)($7.0m)($8.0m)($8.0m)20232023202420242025202520262026